You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CML-AP

Showing 1 - 25 of 858
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Terminated
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Jacksonville, Florida
  • +9 more
Nov 6, 2021

Chronic Myeloid Leukemia Trial in Worldwide (KRT-232, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Birmingham, Alabama
  • +25 more
Mar 4, 2022

Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Bordeaux, Aquitaine, France
  • +11 more
Dec 6, 2020

Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

Completed
Has Results
  • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
  • Loma Linda, California
  • +35 more
Mar 25, 2021

Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

Recruiting
  • Healthy (For Part A)
  • Chronic Myeloid Leukemia (for Part B and C)
  • Vodobatinib (K0706) capsules
  • Downey, California
  • +69 more
Dec 7, 2022

3rd Line Therapy or More to Treat Adult CML- CP in Real World

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Oct 16, 2023

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • +3 more
  • Duarte, California
  • +100 more
Jun 8, 2021

Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia Trial in Worldwide (Ponatinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Ph+ Acute Lymphoblastic Leukemia
  • St Leonards, New South Wales, Australia
  • +41 more
Jan 18, 2021

CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

Recruiting
  • CML, Chronic Phase
  • CML, Accelerated Phase
  • HS-10382(Part 1: Dose escalation)
  • HS-10382(Part 2: Dose expansion)
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023

Chronic Myeloid Leukemia (CML) Trial in Italy (Ponatinib 15mg QD, Ponatinib 30mg QD)

Not yet recruiting
  • Chronic Myeloid Leukemia (CML)
  • Ponatinib 15mg QD
  • Ponatinib 30mg QD
  • Cagliari, Italy
  • +12 more
Jan 31, 2021

Chronic Myeloid Leukemia Trial in Germany (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Mannheim, Baden-Wuerttemberg, Germany
  • +69 more
Mar 21, 2022

3L+ Therapies Among Chronic Myeloid Leukemia and Those With

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis Investigative Site
    Nov 11, 2022

    Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

    Not yet recruiting
    • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    • (no location specified)
    Jul 11, 2022

    Trial (Olverembatinib)

    Available
      • (no location specified)
      Nov 10, 2022

      Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Treatment-free Remission
      • TFR(Treatment-Free Remission)
      • (no location specified)
      Jun 27, 2022

      Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

      Recruiting
      • Chronic Myelogenous Leukemia - Chronic Phase
      • Birmingham, Alabama
      • +25 more
      Jan 10, 2023

      Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

      Recruiting
      • Chronic Myeloid Leukemia in Myeloid Blast Crisis
      • +3 more
      • based decitabine and olverembatinib（HQP1351)chemotherapy
      • Guanzhou, China
        Department of Hematology, Nanfang Hospital, Southern Medical Uni
      Dec 6, 2022

      Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

      Recruiting
      • Chronic Myelogenous Leukemia
      • ABL001 40mg BID
      • +2 more
      • Caba, Buenos Aires, Argentina
      • +53 more
      Jan 27, 2023

      Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

      Recruiting
      • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
      • Longmont, Colorado
      • +128 more
      Aug 1, 2022

      Leukemia Trial in Houston (Ponatinib)

      Terminated
      Has Results
      • Leukemia
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Sep 16, 2019

      Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

      Completed
      • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
      • Angers, France
      • +9 more
      Aug 17, 2022

      CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

      Not yet recruiting
      • CML, Chronic Phase
      • Harbin, Heilongjiang, China
        Institute of Hematology and Oncology, Harbin The First Hospital
      May 5, 2022

      CML Any Phase of the Disease Treated With Ponatinib (Iclusig®)

      Active, not recruiting
      • Chronic Myeloid Leukemia
        • Saint-Pierre, Reunion, France
        • +39 more
        Dec 13, 2021

        Describe Real World Use of Bosutinib inSingle Centre in Scotland

        Completed
        • Myeloid Leukemia
        • Glasgow, United Kingdom
          eatson West of Scotland Cancer Centre
        May 3, 2022